- ranked No. 13 on the list -
BELLEVILLE, ON, Jan. 14 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC), a
research-based, technology-driven Canadian biopharmaceutical company, is
pleased to be named among the Top 50 Best Small and Medium Employers in
Canada. Bioniche was ranked number 13 by its employees.
The rankings are primarily determined using the results from employee
opinion surveys, where 18 key engagement drivers are detailed and analyzed.
The evaluation process also includes the assessment of organization practices
and perspectives from the leadership team. This year, more than 250 companies
across Canada registered to participate in the study.
"We are proud to be selected one of the top small and medium employers in
Canada by our employees, particularly as this is our first time participating
in this process," said Graeme McRae, Chairman, President & CEO of Bioniche
Life Sciences Inc. "Our employees, who are also shareholders in the Company,
are our greatest asset. We appreciate their ongoing support and dedication."
Becoming a Top Best Small and Medium Employer is a very detailed and
competitive process. This national awards program recognizes top employers
with between 50 and 400 employees. This study mirrors the renowned Best
Employer in Canada initiative run by partner, Hewitt Associates; however,
caters to smaller businesses. The study, now in its fifth year, is published
in the Globe and Mail.
Study partners include Queen's School of Business, Queen's Centre for
Business Venturing and Hewitt Associates. More information about the Best
Small & Medium Employers in Canada is available online at
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-driven
Canadian biopharmaceutical company focused on the discovery, development,
manufacturing, and marketing of proprietary products for human and animal
health markets worldwide. The fully-integrated company employs approximately
200 skilled personnel and has three operating divisions: Human Health, Animal
Health, and Food Safety. The Company's primary goal is to develop proprietary
cancer therapies supported by revenues from marketed products in human and
animal health. Bioniche has been named one of Canada's Top Ten Life Sciences
Companies for 2008. For more information, please visit www.Bioniche.com.
Except for historical information, this news release may contain
forward-looking statements that reflect the Company's current expectation
regarding future events. These forward-looking statements involve risk and
uncertainties, which may cause, but are not limited to, changing market
conditions, the successful and timely completion of clinical studies, the
establishment of corporate alliances, the impact of competitive products and
pricing, new product development, uncertainties related to the regulatory
approval process, and other risks detailed from time to time in the Company's
ongoing quarterly and annual reporting.
For further information:
For further information: Jennifer Shea, Vice-President, Communications,
Investor & Government Relations, Bioniche Life Sciences Inc., Telephone: (613)
966-8058, Cell: (613) 391-2097, Jennifer.Shea@Bioniche.com